Columvi
Glofitamab
| Registration | FEI | Name | Status | Initial importer | Expiration year | Address |
|---|---|---|---|---|---|---|
| 2917293 | 2917293 | GENENTECH, INC. | 1 | Y | 2020-04-25 | 1 DNA Way South San Francisco CA US 94080 |
| Source GUDID | Product | Phone | |
|---|---|---|---|
| 00810042590007 | Susvimo - Susvimo Initial Fill Needle | 1-888-835-2555 | xx@xx.xx |
Glofitamab
ALECTINIB HYDROCHLORIDE
Trastuzumab
tocilizumab
tocilizumab
tocilizumab
tocilizumab
vismodegib
Mosunetuzumab
tocilizumab
Pertuzumab
ocrelizumab
Mosunetuzumab
Risdiplam
tenecteplase
Mosunetuzumab
Mosunetuzumab
Risdiplam
omalizumab
omalizumab
omalizumab
pertuzumab, trastuzumab, and hyaluronidase-zzxf
pertuzumab, trastuzumab, and hyaluronidase-zzxf
ocrelizumab and hyaluronidase
BALOXAVIR MARBOXIL
Baloxavir Marboxil
Baloxavir Marboxil
ENTRECTINIB
COBIMETINIB
BALOXAVIR MARBOXIL
BALOXAVIR MARBOXIL
atezolizumab
atezolizumab
emicizumab
emicizumab
emicizumab
emicizumab
emicizumab
emicizumab
atezolizumab and hyaluronidase-tqjs
2024-07-01
2024-07-01
2021-11-29
2021-11-29
2021-11-29
2021-11-29